Limited proteolysis and oxidative modification of proteins in the hepatocytes of patients with resistant forms of tuberculosis

1Todoriko LD, Petrenko VI, Denysov OS, Semіaniv IO, Sprynsіan TA, Pidverbetska OV. Severe cases of tuberculosis and substantiation of ways to influence the increase of treatment efficacy according to standard schemes. Tuberculosis, Lung Diseases, HIV-Infection. 2018;33(2): 7–13.TodorikoLDPetrenkoVIDenysovOSSemіanivIOSprynsіanTAPidverbetskaOVSevere cases of tuberculosis and substantiation of ways to influence the increase of treatment efficacy according to standard schemesTuberculosis, Lung Diseases, HIV-Infection2018332713Search in Google Scholar

2Zheng Y, Ma S, Tan D, Lu M. A meta-analysis of liver lesions in hepatitis B patients undergoing antituberculosis therapy. Chinese Journal of Hepatology. 2014;22(8): 585–589.ZhengYMaSTanDLuMA meta-analysis of liver lesions in hepatitis B patients undergoing antituberculosis therapyChinese Journal of Hepatology2014228585589Search in Google Scholar

3Suriawinata AA, Thung SN. Liver pathology. An Atlas and Concise Guide. New York: Demosmedical; 2011.SuriawinataAAThungSNLiver pathology. An Atlas and Concise GuideNew YorkDemosmedical2011Search in Google Scholar

4Galimova SF. Medicinal lesions of the liver. Hepatology. 2012;(3): 38–48.GalimovaSFMedicinal lesions of the liverHepatology201233848Search in Google Scholar

5Bushnell G, Stennis NL, Drobnik AM, Proops DC, Ahuja SD, Bornschlegel K, et al. Characteristics and TB treatment outcomes in TB patients with viral hepatitis, New York City, 2000–2010. Epidemiology and Infection. 2015;143(9): 972–981.BushnellGStennisNLDrobnikAMProopsDCAhujaSDBornschlegelKCharacteristics and TB treatment outcomes in TB patients with viral hepatitis, New York City, 2000–2010Epidemiology and Infection2015143997298110.1017/S095026881400297025387450Search in Google Scholar

6Feshchenko YuI, Todoriko LD, Kuzhko MM, Humenіuk MI. Tuberculosis pathomorphosis – the realities of today, chemoresistance as a sign of progression. Ukrainian Pulmonology Journal. 2018;(2): 6–10.FeshchenkoYuITodorikoLDKuzhkoMMHumenіukMITuberculosis pathomorphosis – the realities of today, chemoresistance as a sign of progressionUkrainian Pulmonology Journal2018261010.31215/2306-4927-2018-100-2-6-10Search in Google Scholar

7Kaplowitz N, DeLeve LD. Drug-induced liver disease. New York: Informa Healthcare; 2007.KaplowitzNDeLeveLDDrug-induced liver diseaseNew YorkInforma Healthcare200710.3109/9781420021141Search in Google Scholar

8Todoriko LD. Immunopathogenesis of drug-resistant tuberculosis from the standpoint of the present. Tuberculosis, Lung Diseases, HIV-Infection. 2017;30(3): 92–98.TodorikoLDImmunopathogenesis of drug-resistant tuberculosis from the standpoint of the presentTuberculosis, Lung Diseases, HIV-Infection20173039298Search in Google Scholar

9WHO. Guidelines for treatment of drug-susceptible tuberculosis and patient care. Geneva: World Health Organization; 2017. Available from: https://apps.who.int/iris/bitstream/handle/10665/255052/9789241550000-eng.pdf.WHOGuidelines for treatment of drug-susceptible tuberculosis and patient careGenevaWorld Health Organization2017Available from: https://apps.who.int/iris/bitstream/handle/10665/255052/9789241550000-eng.pdf.Search in Google Scholar

10Cheng YJ, Li YL. Antituberculosis treatment and hepatotoxicity in patients with chronic viral hepatitis. Lung. 2014;192(1): 205–210.ChengYJLiYLAntituberculosis treatment and hepatotoxicity in patients with chronic viral hepatitisLung2014192120521010.1007/s00408-013-9535-824292367Search in Google Scholar

11Zozulіak VI. Timely detection of signs of liver dysfunction in patients with destructive tuberculosis. Proceeding of the: XV Congress of the World Federation of Ukrainian Medical Associations. Kyiv – Chernivtsi; 2014, p. 54.ZozulіakVITimely detection of signs of liver dysfunction in patients with destructive tuberculosisProceeding of the: XV Congress of the World Federation of Ukrainian Medical AssociationsKyiv – Chernivtsi201454Search in Google Scholar

12Oprea C, Ianache I, Radoi R, Erscoiu S, Tardei G, Nicolaescu O, et al. Alarming increase in tuberculosis and hepatitis C virus (HCV) among HIV infected intravenous drug users. Journal of International AIDS Society. 2014;17(4): 912–920.OpreaCIanacheIRadoiRErscoiuSTardeiGNicolaescuOAlarming increase in tuberculosis and hepatitis C virus (HCV) among HIV infected intravenous drug usersJournal of International AIDS Society201417491292010.7448/IAS.17.4.19625422486225394129Search in Google Scholar

13Men’shchikova EB, Lankin VZ, Zenkov NK. Oxidative stress. Pro-oxidants and anti-oxidants. Moscow: Slovo; 2006.Men’shchikovaEBLankinVZZenkovNKOxidative stress. Pro-oxidants and anti-oxidantsMoscowSlovo2006Search in Google Scholar

14Protsіuk RH. The problem of co-infection of tuberculosis, HIV-infection and viral hepatitis B and C in the world and Ukraine. Proceeding of the: XV Congress of the World Federation of Ukrainian Medical Associations. Kyiv – Chernivtsi; 2014. p. 48.ProtsіukRHThe problem of co-infection of tuberculosis, HIV-infection and viral hepatitis B and C in the world and UkraineProceeding of the: XV Congress of the World Federation of Ukrainian Medical AssociationsKyiv – Chernivtsi201448Search in Google Scholar